The Latest Breaking News on Pharma

Theranos founder Elizabeth Holmes' prison sentence is finally starting, and her portrayer in The Dropout, Amanda Seyfried, shared her thoughts.

The pharmaceutical industry’s inelastic demand for its products helps it to weather economic downturns. With fears of an impending recession playing on the minds of investors, it could be wise to buy fundamentally strong pharmaceutical stock AbbVie (ABBV). On the other hand, given its mixed fundamentals and profitability, it could…

The 2nd Circuit Court of Appeals in New York cleared the way for a controversial bankruptcy deal that grants immunity from opioid lawsuits to members of the Sackler family.

Four people on using the nostril-based antidote to opioid overdoses, newly approved for over-the-counter sale

The drug store industry is well positioned for long-term growth thanks to the growing demand for prescription drugs. Let’s compare CVS Health (CVS) and MedAvail (MDVL) in this space to determine which is better positioned to capitalize on the industry’s solid growth prospects….

"Whilst the national report looked pretty daunting I’ve not found anything for significant cause for concern"

THE UK’S response to the Covid pandemic has been branded “colonial” and “fuelled by nationalism” by justice campaigners.

Funding for drug treatment centers in Oregon, financed by the state’s pioneering drug decriminalization policy, stands these days at over a quarter-billion dollars

Morris & Dickson Co.'s license has been revoked by the US Drug Enforcement Administration (DEA) following a 68-page order by DEA Administrator Anne Milgram on the opioid crisis

The agency says it will strip Morris & Dickson of its license to sell highly addictive painkillers after finding it failed to flag thousands of suspicious orders at the height of the opioid crisis.

The U.S. Drug Enforcement Administration has stripped one of the nation’s largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis